id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-D-0094-0005,FDA,FDA-2006-D-0094,Guidance for Industry and Food and Drug Administration Staff; Availability: Class II Special Controls; Topical Oxygen Chamber for Extremities;  Availability; Correction,Rule,NCR-Notice of Correction,2011-05-20T04:00:00Z,2011,5,2011-05-20T04:00:00Z,,2011-05-20T13:29:50Z,2011-12409,0,0,0900006480db8764
FDA-2006-D-0094-0004,FDA,FDA-2006-D-0094,Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Topical Oxygen Chamber for Extremities,Other,GDL-Guidance,2011-04-26T04:00:00Z,2011,4,2011-04-26T04:00:00Z,,2011-04-26T12:17:48Z,,0,0,0900006480c3860b
FDA-2006-D-0094-0003,FDA,FDA-2006-D-0094,Guidance for Industry and Food and Drug Administration Staff; Availability: Class II Special Controls Guidance Document: Topical Oxygen Chamber for Extremities,Notice,NAD-Notice of Availability of Data,2011-04-25T04:00:00Z,2011,4,2011-04-25T04:00:00Z,,2011-04-25T18:52:36Z,2011-09898,0,0,0900006480c37268